Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced that John W. Smither, who served as Arcutis’...
AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement of an investigator initiated Phase 2 study...
Epic’s non-cutting technology to modulate the epigenome advances with the addition of new hypercompact Cas effectors and potent gene activators.
Epic Bio, a biotechnology company...
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the release of the PrecivityAD2 blood test, a clinical care assay that meets the...
Element Biosciences, Inc., developer of the Element AVITI System, an innovative DNA sequencing platform that is disrupting the genomics industry, unveiled five new products...
